AKT1 and non-small cell lung carcinoma: The most interesting findings of this study were that in Italian NSCLC patients activation of AKT was associated with advanced stage and higher grade and that, in these tumours, the major determinant of AKT activation was the over-expression of the catalytic subunit of phosphatidylinositol 3-kinase, p110α.